Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
sex decrease » step decrease (Expand Search), we decrease (Expand Search), sizes decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
sex decrease » step decrease (Expand Search), we decrease (Expand Search), sizes decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
1741
-
1742
ALK inhibitors (Positive control) and ABT199 (Proposed binding) in complex with the ALK active side.
Published 2025Subjects: -
1743
-
1744
-
1745
-
1746
Combination therapy exhibited apoptosis in Ba/F3 EML4-ALKmutant cell models.
Published 2025Subjects: -
1747
-
1748
-
1749
Downregulation of miR-1247-3p inhibited apoptosis and reduced chemosensitivity in cells.
Published 2024Subjects: -
1750
-
1751
-
1752
Overexpression of miR-1247-3p promoted apoptosis and inhibited resistance in drug-resistant cells.
Published 2024Subjects: -
1753
Amino acids interactions and binding energy describe that ABT-199 binds to ALK<sup>Mutant</sup>.
Published 2025Subjects: -
1754
BCL2 antiapoptotic protein exhibits heterogeneous expression in Ba/F3 EML4-ALK<sup>mutants</sup>.
Published 2025Subjects: -
1755
Ba/F3 EML4-ALK<sup>mutants</sup> exhibit variable dose-response to ABT-199 treatment.
Published 2025Subjects: -
1756
Molecular docking showed that ABT-199 can fit into active site of ALK<sup>Mutant</sup>.
Published 2025Subjects: -
1757
-
1758
-
1759
-
1760
HSF2 is a positive regulator of EBV spontaneous lytic cycle in gastric epithelial cells.
Published 2025Subjects: